Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral amyloid angiopathy and vessel dysfunction.

Steven M Greenberg1

  • 1Department of Neurology, Massachusetts General Hospital, Boston, Mass 02114, USA. greenberg@helix.mgh.harvard.edu

Cerebrovascular Diseases (Basel, Switzerland)
|March 20, 2002
PubMed
Summary

Cerebral amyloid angiopathy (CAA) contributes to hemorrhagic stroke and may also cause vessel dysfunction, reduced cerebral blood flow, and ischemia. Beta-amyloid deposition in brain vessels is a key factor in these effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same author

Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Long-Term Blood Pressure Variability in Cerebral Amyloid Angiopathy is Associated with Ischemic Brain Injury and Cognitive Decline.

Journal of the American Heart Association·2026
Same author

Longitudinal multiphoton imaging of cerebral amyloid angiopathy in response to anti-ApoE4 immunotherapy in mice.

Molecular neurodegeneration·2026
Same author

Utility of the Medical Knowledge AI Copilot, OpenEvidence: A Patient With 100 Cerebral Microhemorrhages.

Cureus·2026
Same author

Vascular Contributions to Cognitive Impairment and Brain Health: Clinical Update and Mechanistic Considerations: A Scientific Statement From the American Heart Association.

Stroke·2026

Area of Science:

  • Neurology
  • Vascular Biology
  • Neurodegenerative Diseases

Background:

  • Cerebral amyloid angiopathy (CAA) is characterized by beta-amyloid peptide deposition in cerebral and meningeal vessels.
  • CAA is a known cause of hemorrhagic stroke.
  • Emerging evidence suggests CAA also contributes to cerebrovascular dysfunction and ischemia.

Purpose of the Study:

  • To review the evidence linking CAA to vessel dysfunction, reduced cerebral blood flow, and ischemia.
  • To discuss the role of beta-amyloid in these pathological processes.
  • To explore the clinical significance of vascular beta-amyloid in dementia.

Main Methods:

  • Literature review of studies on cerebral amyloid angiopathy.
  • Analysis of clinical data from hereditary and sporadic CAA cases.

Related Experiment Videos

  • Examination of findings from transgenic mouse models of CAA.

    • Main Results:

    • Accumulating evidence supports CAA's role in causing vessel dysfunction, reduced cerebral blood flow, and ischemic lesions.
    • Ischemic lesions are observed in hereditary CAA syndromes and some sporadic CAA patients.
    • Transgenic mouse data suggest mechanisms by which beta-amyloid impacts vessel physiology.

    Conclusions:

    • CAA is implicated not only in hemorrhagic stroke but also in cerebrovascular dysfunction and ischemia.
    • Beta-amyloid deposition in cerebral vessels plays a critical role in these pathologies.
    • Vascular beta-amyloid represents a potential therapeutic target for dementia.